|Price and Volume|
|52 Week High||29.32|
|52 Week Low||6.56|
|Avg. Daily Vol. (Mil)||0.26|
|Beta (3 year)||0.00|
|Share Related Items|
|Mkt Cap (Mil)||495.69|
|Shares Out (Mil)||24.10|
|LT Debt/ Equity||0.08|
|Total Debt / Equity||0.11|
|Per Share Data|
|Aratana Therapeutics Inc is a development-stage biopharmaceutical company. It is engaged in licensing, development and commercialization of prescription medicines for pets.|
|1901 Olathe Boulevard
|Industry : Drugs|
|Sector: Health Care|
|CEO: Dr. Steven St. Peter,M.D|
|Current Month (Mil)||0.75|
|Previous Month (Mil)||0.64|
|Short Interest Ratio (Days)||1.70|
|Return on Equity||n.a.|
|Return on Assets||-29.60|
|Return on Investments||-32.80|
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.